Pain control in augmentation mammaplasty using indwelling catheters in 687 consecutive patients: data analysis

Area of Science:

• Plastic Surgery
• Pain Management
• Anesthesiology

Background:

• Postoperative pain following augmentation mammaplasty significantly impacts patient recovery and quality of life.
• Previous studies indicated indwelling catheters with bupivacaine are safe and effective for pain management.
• This study aimed to further evaluate pain management strategies in a larger patient cohort.

Purpose of the Study:

• Compare the efficacy of indwelling catheter pain control versus systemic analgesics.
• Identify specific sites of postoperative pain after augmentation mammaplasty.
• Determine factors influencing postoperative pain levels and analgesic preferences.

Main Methods:

• A large population of augmentation mammaplasty patients completed questionnaires on pain reduction, analgesic preference, and pain locations.
• Statistical analysis investigated correlations between pain and patient factors (age, fear, pain tolerance) and operative aspects (implant size, dissection technique).

Main Results:

• 89% of patients experienced pain reduction with self-administered bupivacaine via catheter.
• Catheter analgesia was preferred and rated comparable to systemic narcotics like Vicodin and Percocet.
• Pain was reported in the chest, sternum, armpits, and shoulders; older patients experienced less pain.
• Sternal pain and higher preoperative fear correlated with longer narcotic use.

Conclusions:

• Postoperative pain management in augmentation mammaplasty can be effectively achieved with indwelling catheters delivering local anesthetics.
• Pain can manifest in areas beyond the breasts, including the chest and shoulders, with sternal pain being particularly severe.
• Factors like implant size and surgical technique did not significantly influence pain, but patient-specific factors like fear may play a role.